A detailed history of Parallel Advisors, LLC transactions in Illumina, Inc. stock. As of the latest transaction made, Parallel Advisors, LLC holds 1,565 shares of ILMN stock, worth $212,871. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,565
Previous 1,495 4.68%
Holding current value
$212,871
Previous $156,000 30.77%
% of portfolio
0.0%
Previous 0.0%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$105.28 - $135.9 $7,369 - $9,513
70 Added 4.68%
1,565 $204,000
Q2 2024

Aug 08, 2024

SELL
$101.05 - $133.57 $874,486 - $1.16 Million
-8,654 Reduced 85.27%
1,495 $156,000
Q1 2024

May 06, 2024

BUY
$127.73 - $147.2 $27,972 - $32,236
219 Added 2.21%
10,149 $1.39 Million
Q4 2023

Feb 09, 2024

SELL
$92.79 - $142.53 $20,506 - $31,499
-221 Reduced 2.18%
9,930 $1.38 Million
Q3 2023

May 20, 2024

SELL
$128.91 - $192.44 $41,766 - $62,350
-324 Reduced 3.09%
10,151 $1.39 Million
Q3 2023

Nov 13, 2023

SELL
$128.91 - $192.44 $41,766 - $62,350
-324 Reduced 3.09%
10,151 $1.39 Million
Q2 2023

May 20, 2024

SELL
$183.43 - $232.67 $9,538 - $12,098
-52 Reduced 0.49%
10,475 $1.96 Million
Q2 2023

Aug 04, 2023

SELL
$183.43 - $232.67 $9,538 - $12,098
-52 Reduced 0.49%
10,475 $1.96 Million
Q1 2023

May 20, 2024

BUY
$193.75 - $232.55 $73,237 - $87,903
378 Added 3.72%
10,527 $2.45 Million
Q1 2023

Apr 25, 2023

SELL
$193.75 - $232.55 $28,868 - $34,649
-149 Reduced 1.4%
10,527 $2.45 Million
Q4 2022

Feb 03, 2023

SELL
$187.24 - $242.74 $74,334 - $96,367
-397 Reduced 3.59%
10,676 $2.16 Million
Q3 2022

Nov 10, 2022

SELL
$177.23 - $227.44 $11,519 - $14,783
-65 Reduced 0.58%
11,073 $2.11 Million
Q2 2022

Aug 01, 2022

SELL
$181.58 - $368.0 $259,840 - $526,608
-1,431 Reduced 11.39%
11,138 $2.05 Million
Q1 2022

Apr 28, 2022

SELL
$303.87 - $423.8 $873,930 - $1.22 Million
-2,876 Reduced 18.62%
12,569 $4.43 Million
Q4 2021

Jan 20, 2022

SELL
$347.28 - $421.83 $112,518 - $136,672
-324 Reduced 2.05%
15,445 $5.88 Million
Q3 2021

Nov 02, 2021

BUY
$405.61 - $524.84 $4.83 Million - $6.25 Million
11,900 Added 307.57%
15,769 $6.4 Million
Q2 2021

Aug 06, 2021

BUY
$372.84 - $481.5 $43,622 - $56,335
117 Added 3.12%
3,869 $1.83 Million
Q1 2021

Apr 23, 2021

BUY
$361.28 - $504.76 $42,992 - $60,066
119 Added 3.28%
3,752 $1.44 Million
Q4 2020

Feb 02, 2021

SELL
$292.7 - $370.96 $141,374 - $179,173
-483 Reduced 11.73%
3,633 $1.34 Million
Q3 2020

Oct 27, 2020

SELL
$268.51 - $400.74 $256,695 - $383,107
-956 Reduced 18.85%
4,116 $1.27 Million
Q2 2020

Jul 16, 2020

SELL
$256.46 - $373.01 $52,061 - $75,721
-203 Reduced 3.85%
5,072 $1.88 Million
Q1 2020

Apr 27, 2020

SELL
$209.2 - $335.53 $408,776 - $655,625
-1,954 Reduced 27.03%
5,275 $1.44 Million
Q4 2019

Jan 30, 2020

BUY
$288.29 - $335.49 $26,522 - $30,865
92 Added 1.29%
7,229 $2.4 Million
Q3 2019

Nov 01, 2019

BUY
$266.84 - $378.23 $33,088 - $46,900
124 Added 1.77%
7,137 $2.17 Million
Q2 2019

Aug 05, 2019

BUY
$300.59 - $368.15 $134,664 - $164,931
448 Added 6.82%
7,013 $2.58 Million
Q1 2019

May 01, 2019

BUY
$272.57 - $321.18 $302,280 - $356,188
1,109 Added 20.33%
6,565 $2.04 Million
Q4 2018

Feb 05, 2019

BUY
$272.46 - $366.54 $305,700 - $411,257
1,122 Added 25.89%
5,456 $1.64 Million
Q3 2018

Nov 01, 2018

BUY
$279.04 - $367.06 $109,941 - $144,621
394 Added 10.0%
4,334 $1.59 Million
Q2 2018

Jul 30, 2018

BUY
$228.17 - $292.07 $85,335 - $109,234
374 Added 10.49%
3,940 $1.1 Million
Q1 2018

May 08, 2018

BUY
$209.54 - $253.91 $7,752 - $9,394
37 Added 1.05%
3,566 $843,000
Q4 2017

Feb 13, 2018

BUY
$202.23 - $230.03 $2,022 - $2,300
10 Added 0.28%
3,529 $771,000
Q3 2017

Nov 15, 2017

BUY
$172.3 - $213.93 $606,323 - $752,819
3,519 New
3,519 $736,000
Q3 2017

Nov 14, 2017

SELL
$172.3 - $213.93 $608,563 - $755,600
-3,532 Closed
0 $0
Q2 2017

Aug 07, 2017

BUY
N/A
3,532
3,532 $614,000

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $21.4B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Parallel Advisors, LLC Portfolio

Follow Parallel Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.